Carrillo Navarrete Karen Adriana, Chapa González Christian
Instituto de Ingeniería y Tecnología Universidad Autónoma de Ciudad Juárez Ciudad Juárez, Chihuahua México.
Grupo de Nanomedicina, Laboratorio de Integración de Datos y Evidencia en Revisiones de Salud y Ciencia, LIDERSC Universidad Autónoma de Ciudad Juárez Ciudad Juárez, Chihuahua México.
Ibrain. 2024 Jan 13;10(1):59-68. doi: 10.1002/ibra.12146. eCollection 2024 Spring.
Acute ischemic stroke is a significant health concern worldwide, often leading to long-term disability and decreased quality of life. Rapid and appropriate treatment is crucial for achieving optimal outcomes in these patients. Intravenous thrombolysis (IVT) and mechanical thrombectomy (MT) are two commonly used interventions for acute ischemic stroke, but their effectiveness in improving neurological symptoms and functional outcomes in patients with hemiplegia remains uncertain. The aim of this work was to evaluate the impact of IVT and MT within a 4.5-h time frame on patients with acute ischemic stroke and hemiplegia. A systematic review was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Relevant studies that assessed the impact of IVT and MT within 4.5-h on hemiplegia in patients with an acute ischemic stroke were included. Data were extracted and analyzed to determine the overall effects of these interventions. Most included case reports indicate positive outcomes in terms of neurological symptom improvement and functional recovery in patients with hemiplegia after receiving IVT and MT within the specified time frame. However, the heterogeneity among the patients and the limited use of IVT due to contraindications posed challenges in determining the most effective treatment option. The findings from the included studies demonstrate that both interventions led to a decrease in National Institutes of Health Stroke Scale scores, indicating an improvement in neurological symptoms. The results highlight the beneficial effects of early thrombolytic interventions and MT on the neurological status and functional outcomes of patients with an acute ischemic stroke.
急性缺血性中风是全球范围内重大的健康问题,常导致长期残疾和生活质量下降。快速且恰当的治疗对于这些患者实现最佳预后至关重要。静脉溶栓(IVT)和机械取栓(MT)是急性缺血性中风常用的两种干预措施,但它们在改善偏瘫患者神经症状和功能结局方面的有效性仍不确定。这项工作的目的是评估在4.5小时时间范围内IVT和MT对急性缺血性中风偏瘫患者的影响。按照系统评价与Meta分析的首选报告项目指南进行了一项系统评价。纳入了评估在4.5小时内IVT和MT对急性缺血性中风患者偏瘫影响的相关研究。提取并分析数据以确定这些干预措施的总体效果。大多数纳入的病例报告表明,在规定时间范围内接受IVT和MT后,偏瘫患者在神经症状改善和功能恢复方面有积极结果。然而,患者之间的异质性以及由于禁忌症导致IVT使用受限,给确定最有效的治疗方案带来了挑战。纳入研究的结果表明,两种干预措施均导致美国国立卫生研究院卒中量表评分降低,表明神经症状有所改善。结果突出了早期溶栓干预和MT对急性缺血性中风患者神经状态和功能结局的有益影响。
Cochrane Database Syst Rev. 2025-4-24
Ont Health Technol Assess Ser. 2016-2-8
Neurotherapeutics. 2025-1
J Soc Cardiovasc Angiogr Interv. 2023-2-23
Front Endocrinol (Lausanne). 2023
J Cereb Blood Flow Metab. 2023-5
Diagnostics (Basel). 2022-10-19